Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Shares Outstanding (Weighted Average): 2011-2024

Historic Shares Outstanding (Weighted Average) for Puma Biotechnology (PBYI) over the last 14 years, with Dec 2024 value amounting to $49.1 million.

  • Puma Biotechnology's Shares Outstanding (Weighted Average) rose 2.70% to $50.4 million in Q3 2025 from the same period last year, while for Dec 2024 it was $49.1 million, marking a year-over-year increase of 1.83%. This contributed to the annual value of $49.1 million for FY2024, which is 1.83% up from last year.
  • As of FY2024, Puma Biotechnology's Shares Outstanding (Weighted Average) stood at $49.1 million, which was up 1.83% from $48.2 million recorded in FY2023.
  • Puma Biotechnology's 5-year Shares Outstanding (Weighted Average) high stood at $49.1 million for FY2024, and its period low was $39.8 million during FY2020.
  • Over the past 3 years, Puma Biotechnology's median Shares Outstanding (Weighted Average) value was $48.2 million (recorded in 2023), while the average stood at $47.6 million.
  • Data for Puma Biotechnology's Shares Outstanding (Weighted Average) shows a peak YoY increased of 11.63% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Puma Biotechnology's Shares Outstanding (Weighted Average) stood at $39.8 million in 2020, then grew by 2.82% to $40.9 million in 2021, then increased by 11.63% to $45.6 million in 2022, then rose by 5.62% to $48.2 million in 2023, then climbed by 1.83% to $49.1 million in 2024.